Weifang Ling

1.5k total citations · 1 hit paper
14 papers, 1.2k citations indexed

About

Weifang Ling is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Weifang Ling has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Weifang Ling's work include Virus-based gene therapy research (4 papers), Mesenchymal stem cell research (4 papers) and Immune cells in cancer (4 papers). Weifang Ling is often cited by papers focused on Virus-based gene therapy research (4 papers), Mesenchymal stem cell research (4 papers) and Immune cells in cancer (4 papers). Weifang Ling collaborates with scholars based in China, United States and Italy. Weifang Ling's co-authors include Arthur I. Roberts, Yufang Shi, Guangwen Ren, Jimin Zhang, Xin Zhao, Liying Zhang, Arnold B. Rabson, Songtao Shi, Anh D. Lê and Changshun Shao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Weifang Ling

14 papers receiving 1.2k citations

Hit Papers

Inflammatory Cytokine-Induced Intercellular Adhesion Mole... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression
    2010 519 citations Guangwen Ren, Xin Zhao et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weifang Ling China 8 895 369 315 307 242 14 1.2k
Shala Yuan Canada 11 696 0.8× 287 0.8× 266 0.8× 256 0.8× 184 0.8× 17 975
Lisa O’Flynn Ireland 15 783 0.9× 388 1.1× 344 1.1× 213 0.7× 139 0.6× 21 1.2k
Marie‐Noëlle Boivin Canada 16 1.1k 1.2× 354 1.0× 483 1.5× 566 1.8× 337 1.4× 24 1.7k
Nayoun Kim South Korea 18 562 0.6× 232 0.6× 313 1.0× 244 0.8× 229 0.9× 40 1.1k
Kelen Cristina Ribeiro Malmegrim Brazil 24 778 0.9× 665 1.8× 508 1.6× 471 1.5× 239 1.0× 63 2.0k
Moutih Rafei Canada 20 672 0.8× 269 0.7× 516 1.6× 588 1.9× 345 1.4× 64 1.7k
Anthony S. Perry United States 10 610 0.7× 385 1.0× 621 2.0× 194 0.6× 223 0.9× 14 1.4k
César Trigueros Spain 24 647 0.7× 340 0.9× 652 2.1× 551 1.8× 276 1.1× 34 1.8k
Tae–Hoon Shin South Korea 20 624 0.7× 226 0.6× 577 1.8× 326 1.1× 156 0.6× 36 1.4k
Fatemeh Talebian United States 14 708 0.8× 334 0.9× 487 1.5× 435 1.4× 287 1.2× 27 1.5k

Countries citing papers authored by Weifang Ling

Since Specialization
Citations

This map shows the geographic impact of Weifang Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifang Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifang Ling more than expected).

Fields of papers citing papers by Weifang Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifang Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifang Ling. The network helps show where Weifang Ling may publish in the future.

Co-authorship network of co-authors of Weifang Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Weifang Ling. A scholar is included among the top collaborators of Weifang Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifang Ling. Weifang Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Qing, Liangyu Lin, Peishun Shou, et al.. (2023). MHC class Ib–restricted CD8 + T cells possess strong tumoricidal activities. Proceedings of the National Academy of Sciences. 120(43). e2304689120–e2304689120. 2 indexed citations
2.
Somanchi, Srinivas S., Xuan Guo, Rohit Mathur, et al.. (2019). Development of CD38 CAR Engineered Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (PNK-CAR38) As Allogeneic Cancer Immunotherapy. Blood. 134(Supplement_1). 2070–2070. 5 indexed citations
3.
Ng, Mah Lee, Weifang Ling, Gunnar F. Kaufmann, et al.. (2019). Preclinical Evaluation of Human Placental-Derived Allogeneic CD19 CAR-T Cells Against B Cell Malignancies. Blood. 134(Supplement_1). 3222–3222. 5 indexed citations
4.
Ling, Weifang, Minyou Chen, Zuolin Wei, et al.. (2016). A distributed optimal control method for active distribution network. 1–6. 4 indexed citations
5.
Ling, Weifang, Jimin Zhang, Zengrong Yuan, et al.. (2014). Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment. Cancer Research. 74(5). 1576–1587. 164 indexed citations
6.
Ren, Guangwen, Xin Zhao, Liying Zhang, et al.. (2010). Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression. The Journal of Immunology. 184(5). 2321–2328. 519 indexed citations breakdown →
7.
Ren, Guangwen, Liying Zhang, Ting Wen, et al.. (2010). Tumor-derived mesenchymal stem cells enhance tumor development via nitric oxide (100.33). The Journal of Immunology. 184(1_Supplement). 100.33–100.33. 1 indexed citations
8.
Ren, Guangwen, Liying Zhang, Juanjuan Su, et al.. (2009). Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression (141.45). The Journal of Immunology. 182(Supplement_1). 141.45–141.45. 8 indexed citations
9.
Ren, Guangwen, Juanjuan Su, Liying Zhang, et al.. (2009). Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression. Stem Cells. 27(8). 1954–1962. 470 indexed citations
10.
Zhu, Huabin, Yue Su, Shumin Zhou, et al.. (2007). Immune analysis on mtHSV mediated tumor therapy in HSV-1 seropositive mice. Cancer Biology & Therapy. 6(5). 724–731. 7 indexed citations
11.
Zhu, Huabin, Baoli Hu, Weifang Ling, et al.. (2006). Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway. Cancer Biology & Therapy. 5(2). 180–188. 8 indexed citations
12.
Feng, Xue, Yue Su, Weifang Ling, et al.. (2005). Tumor-targeted therapy with a conditionally replicating mutant of HSV-1 induces regression of xenografted human hepatomas. Cancer Biology & Therapy. 4(11). 1234–1239. 6 indexed citations
13.
Yi, Guohua, Yipeng Qi, Yingle Liu, et al.. (2005). Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library. Biochemical and Biophysical Research Communications. 329(2). 437–444. 18 indexed citations
14.
Hu, Baoli, Songbo Qiu, Yue Su, et al.. (2004). Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins. Biochemical and Biophysical Research Communications. 325(4). 1153–1162. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shala Yuan Breakdown of academic impact, for papers by Lisa O’Flynn Breakdown of academic impact, for papers by Marie‐Noëlle Boivin Breakdown of academic impact, for papers by Nayoun Kim Breakdown of academic impact, for papers by Kelen Cristina Ribeiro Malmegrim Breakdown of academic impact, for papers by Moutih Rafei Breakdown of academic impact, for papers by Anthony S. Perry Breakdown of academic impact, for papers by César Trigueros Breakdown of academic impact, for papers by Tae–Hoon Shin Breakdown of academic impact, for papers by Fatemeh Talebian
Rankless by CCL
2026